A Risk Model for 28-Day in-Hospital Mortality in 173 COVID-19 Patients Admission to ICU: A Retrospective Study

References

• Rahmandad H, Lim TY, Sterman J. Behavioral dynamics of COVID-19: estimating underreporting, multiple waves, and adherence fatigue across 92 nations. Syst Dyn Rev. 2021;37(1):5–31. doi:10.1002/sdr.1673
   PubMed Web of Science ®Google Scholar
• Kuo CL, Pilling LC, Atkins JC, et al. COVID-19 severity is predicted by earlier evidence of accelerated aging. medRxiv. 2020;2:3.
   Google Scholar
• Abbasi-Oshaghi E, Mirzaei F, Farahani F, Khodadadi I, Tayebinia H. Diagnosis and treatment of coronavirus disease 2019 (COVID-19): laboratory, PCR, and chest CT imaging findings. Int J Surg. 2020;79:143–153. doi:10.1016/j.ijsu.2020.05.018
   PubMed Web of Science ®Google Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239–1242. doi:10.1001/jama.2020.2648
   PubMed Web of Science ®Google Scholar
• Grigonis AM, Mathews KS, Benka-Coker WO, Dawson AM, Hammerman SI. Long-term acute care hospitals extend ICU capacity for COVID-19 response and recovery. Chest. 2021;159(5):1894–1901. doi:10.1016/j.chest.2020.12.001
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Wang Z, Wu P, Wang L, et al. Marginal effects of public health measures and COVID-19 disease burden in China: a large-scale modelling study. PLoS Comput Biol. 2023;19(9):e1011492. doi:10.1371/journal.pcbi.1011492
   PubMed Web of Science ®Google Scholar
• Kwok KO, Huang Y, Tsoi MTF, et al. Epidemiology, clinical spectrum, viral kinetics and impact of COVID-19 in the Asia-Pacific region. Respirology. 2021;26(4):322–333. doi:10.1111/resp.14026
   PubMed Web of Science ®Google Scholar
• Kim L, Garg S, O’Halloran A, et al. Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US coronavirus disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET). Clin Infect Dis. 2021;72(9):e206–e214. doi:10.1093/cid/ciaa1012
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847. doi:10.1111/jth.14768
   PubMed Web of Science ®Google Scholar
• Barbaro RP, MacLaren G, Boonstra PS, et al. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the extracorporeal life support organization registry. Lancet. 2020;396(10257):1071–1078. doi:10.1016/S0140-6736(20)32008-0
   PubMed Web of Science ®Google Scholar
• Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. doi:10.1136/bmj.m1091
   PubMed Web of Science ®Google Scholar
• Khalid A, Ali Jaffar M, Khan T, et al. Hematological and biochemical parameters as diagnostic and prognostic markers in SARS-COV-2 infected patients of Pakistan: a retrospective comparative analysis. Hematology. 2021;26(1):529–542. doi:10.1080/16078454.2021.1950898
   PubMed Web of Science ®Google Scholar
• Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934–943. doi:10.1001/jamainternmed.2020.0994
   PubMed Web of Science ®Google Scholar
• Shang Y, Liu T, Wei Y, et al. Scoring systems for predicting mortality for severe patients with COVID-19. EClinicalMedicine. 2020;24:100426. doi:10.1016/j.eclinm.2020.100426
   PubMedGoogle Scholar
• Knight SR, Ho A, Pius R, et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020;370:m3339.
   PubMed Web of Science ®Google Scholar
• Cheng J, Sollee J, Hsieh C, et al. COVID-19 mortality prediction in the intensive care unit with deep learning based on longitudinal chest X-rays and clinical data. Eur Radiol. 2022;32(7):4446–4456. doi:10.1007/s00330-022-08588-8
   PubMed Web of Science ®Google Scholar
• Tahavvori A, Mosaddeghi-Heris R, Ghanbari Sevari F, et al. Combined systemic inflammatory indexes as reflectors of outcome in patients with COVID‑19 infection admitted to ICU. Inflammopharmacology. 2023;31(5):2337–2348. doi:10.1007/s10787-023-01308-8
   PubMed Web of Science ®Google Scholar
• de Gonzalo-Calvo D, Molinero M, Benítez ID, et al. A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study. Respir Res. 2023;24(1):159. doi:10.1186/s12931-023-02462-x
   PubMed Web of Science ®Google Scholar
• Angriman F, Ferreyro BL, Harhay MO, Wunsch H, Rosella LC, Scales DC. Accounting for competing events when evaluating long-term outcomes in survivors of critical illness. Am J Respir Crit Care Med. 2023;208(11):1158–1165. doi:10.1164/rccm.202305-0790CP
   PubMed Web of Science ®Google Scholar
• Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Statis Assoc. 1999;94(446):496–509. doi:10.1080/01621459.1999.10474144
   Web of Science ®Google Scholar
• Obuchowski NA, Bullen JA. Receiver operating characteristic (ROC) curves: review of methods with applications in diagnostic medicine. Phys Med Biol. 2018;63(7):07TR01. doi:10.1088/1361-6560/aab4b1
   PubMed Web of Science ®Google Scholar
• Brien WF, Crawford L, Raby A, Richardson H. In-house calibration of the international sensitivity index or calibration curve for determination of the international normalized ratio. Arch Pathol Lab Med. 2004;128(3):308–312. doi:10.5858/2004-128-308-ICOTIS
   PubMed Web of Science ®Google Scholar
• Chen Y, Klein SL, Garibaldi BT, et al. Aging in COVID-19: vulnerability, immunity and intervention. Ageing Res Rev. 2021;65:101205. doi:10.1016/j.arr.2020.101205
   PubMed Web of Science ®Google Scholar
• Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi:10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar
• Levin AT, Hanage WP, Owusu-Boaitey N, Cochran KB, Walsh SP, Meyerowitz-Katz G. Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications. Eur J Epidemiol. 2020;35(12):1123–1138. doi:10.1007/s10654-020-00698-1
   PubMed Web of Science ®Google Scholar
• Shaw AC, Joshi S, Greenwood H, Panda A, Lord JM. Aging of the innate immune system. Curr Opin Immunol. 2010;22(4):507–513. doi:10.1016/j.coi.2010.05.003
   PubMed Web of Science ®Google Scholar
• Gao YD, Ding M, Dong X, et al. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. 2021;76(2):428–455. doi:10.1111/all.14657
   PubMed Web of Science ®Google Scholar
• Liu Y, Du X, Chen J, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81(1):e6–e12. doi:10.1016/j.jinf.2020.04.002
   Web of Science ®Google Scholar
• Laforge M, Elbim C, Frère C, et al. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat Rev Immunol. 2020;20(9):515–516. doi:10.1038/s41577-020-0407-1
   PubMed Web of Science ®Google Scholar
• Cai J, Li H, Zhang C, et al. The neutrophil-to-lymphocyte ratio determines clinical efficacy of corticosteroid therapy in patients with COVID-19. Cell Metab. 2021;33(2):258–269.e253. doi:10.1016/j.cmet.2021.01.002
   PubMed Web of Science ®Google Scholar
• Bedel C, Korkut M. Neutrophil-to-lymphocyte ratio and covid-19. Shock. 2021;56(5):874. doi:10.1097/SHK.0000000000001712
   PubMed Web of Science ®Google Scholar
• Yadav DK, Singh A, Zhang Q, et al. Involvement of liver in COVID-19: systematic review and meta-analysis. Gut. 2021;70(4):807–809. doi:10.1136/gutjnl-2020-322072
   PubMed Web of Science ®Google Scholar
• Bender JM, Worman HJ. Coronavirus disease 2019 and liver injury: a retrospective analysis of hospitalized patients in New York City. J Clin Transl Hepatol. 2021;9(4):551–558. doi:10.14218/JCTH.2020.00171
   PubMed Web of Science ®Google Scholar
• Ding ZY, Li GX, Chen L, et al. Association of liver abnormalities with in-hospital mortality in patients with COVID-19. J Hepatol. 2021;74(6):1295–1302. doi:10.1016/j.jhep.2020.12.012
   PubMed Web of Science ®Google Scholar
• Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol. 2020;52(6):1193–1194. doi:10.1007/s11255-020-02451-9
   PubMed Web of Science ®Google Scholar
• Sullivan MK, Lees JS, Drake TM, et al. Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study. Nephrol Dial Transplant. 2022;37(2):271–284. doi:10.1093/ndt/gfab303
   PubMed Web of Science ®Google Scholar
• Chu KH, Tsang WK, Tang CS, et al. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int. 2005;67(2):698–705. doi:10.1111/j.1523-1755.2005.67130.x
   PubMed Web of Science ®Google Scholar
• Soleimani M. Acute kidney injury in SARS-CoV-2 infection: direct effect of virus on kidney proximal tubule cells. Int J Mol Sci. 2020;21(9):3275. doi:10.3390/ijms21093275
   PubMed Web of Science ®Google Scholar
• Donnelly CA, Ghani AC, Leung GM, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 2003;361(9371):1761–1766. doi:10.1016/S0140-6736(03)13410-1
   PubMed Web of Science ®Google Scholar
• Thomas G. Renin-angiotensin system inhibitors in COVID-19. Cleve Clin J Med. 2020. doi:10.3949/ccjm.87a.ccc009
   Web of Science ®Google Scholar